Related Experiment Video
Updated: Jul 9, 2026
13:41
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
[Quadrivalent HPV 6/11/16/18 vaccine].
Susanne Krüger Kjaer1, Erik Søgård Andersen, Henning Djursing
1Rigshospitalet, Juliane Marie Center, Kraeftens Bekaempelse, Institut for Epidemiologisk Kraeftforskning, Aalborg Sygehus. susanne@cancer.dk
Ugeskrift for Laeger
|December 15, 2007
Summary
The quadrivalent HPV vaccine significantly prevents cervical precancers caused by HPV 16/18 in women. This human papillomavirus vaccine demonstrated high efficacy in preventing high-grade cervical lesions.
Area of Science:
- Oncology
- Immunology
- Virology
Context:
- Cervical cancer remains a significant global health concern.
- Human papillomavirus (HPV) is the primary cause of cervical cancer.
- Quadrivalent HPV vaccine targets HPV types 6, 11, 16, and 18.
Purpose:
- To evaluate the efficacy of the quadrivalent HPV vaccine in preventing cervical intraepithelial neoplasia (CIN) and adenocarcinoma in situ (AIS).
- To assess vaccine effectiveness across different exposure statuses to HPV types 16 and 18.
Summary:
- A randomized, double-blind study involving 12,167 women assessed the quadrivalent HPV vaccine (types 6/11/16/18) over 3 years.
- The vaccine achieved 98% efficacy against HPV 16/18-related CIN2/CIN3/AIS in previously unexposed women and 44% efficacy in the overall cohort.
- Overall vaccine efficacy against all high-grade cervical lesions, irrespective of HPV type, was 17%.
Impact:
- Demonstrates substantial protection against HPV-related cervical precancers, particularly in HPV-naive populations.
- Provides crucial data supporting HPV vaccination programs for cervical cancer prevention.
- Highlights the importance of HPV type-specific efficacy and overall population impact.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:20Chickenpox
Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:51Vaccinations
Overview
01:23Genital Herpes
Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...